UK based Care Fertility has today announced new partnerships with the US based Reach Fertility and Spanish based IVF-Life. These are the latest of several fertility clinic transactions by Care Fertility,
Nottingham, UK, Dec. 13, 2022 – UK Based Care Fertility, A leading IVF group in the UK and one of the leaders globally in the treatment of infertility has backed by private equity investor Nordic Capital, has a reputation for innovation, clinical excellence, a unique patient proposition and delivering strong success rates for all patients.
Dr. Seth Katz, the medical director at REACH Fertility says, “this partnership is a reflection of our shared vision and values with Care Fertility and we look forward to enhancing access to innovative care and cutting-edge reproductive medicine for all our patients.”
The partnerships with REACH Fertility, IVF-Life and Integrated Genetic Laboratory Services (IGLS) will enable Care to leverage its expertise, innovation and outstanding patient care across international markets. Despite the global economic challenges, the demand for fertility treatment remains strong. This is largely due to rising infertility cases and an increasing trend of delaying pregnancy for various reasons.
“Our Spanish partnership delivers an exciting opportunity for both Care Fertility, IVF-Life and IGLS to give patients a seamless experience across borders, whilst the essence of the US partnership is the creation of key synergies and the opportunity to bring some of Care’s unique innovations to the US market,” explains David Burford, CEO of Care Fertility group.
Dr. Jon Aizpurua, President and founder of IVF-Life and IGLS comments: “We are confident that the synergies between Care Fertility, IVF-Life and IGLS, will contribute to the worldwide expansion of our footprint in the assisted reproduction market by offering an increasingly wider scope of personalized fertility treatments, facilitating the continuous development of ground-breaking solutions for patients across the globe.”
Over the last twenty-five years, patients have travelled from around the world to access treatment at some of Care’s world-leading clinics in the UK. Care’s expansion to the US and Spain provides an important first step in delivering greater accessibility for international patients. In addition, the partnership with IGLS will enhance Care’s provision of genetic and immunology solutions for the whole IVF treatment pathway.
“Nordic Capital is delighted to support this exciting new stage in Care Fertility’s growth. We see it as an opportunity to access key new markets and leverage the underlying tools, platform and innovation that Care Fertility have created. We welcome IVF-Life, IGLS and REACH Fertility to the Care Fertility Group,” Alfa Chan, Partner, Nordic Capital Advisors.
News Resource – prnewswire.co.uk, December 13, 2022
